Alpine Immune Sciences is a clinical stage biopharmaceutical company based in Seattle, WA. They are dedicated to discovering and developing innovative protein-based immunotherapies for inflammatory autoimmune diseases and cancer. With a focus on improving outcomes for patients with severe inflammatory and autoimmune diseases, Alpine Immune Sciences utilizes unique protein engineering strategies, including the directed evolution of immune proteins into novel, multi-targeted therapeutics.
Since their launch in 2015, Alpine Immune Sciences has advanced multiple product candidates into clinical trials, formed collaborations with world-class partners, and built a robust development pipeline. Their diverse pipeline targets autoimmune and inflammatory diseases, and they aim to revolutionize immunotherapy through their next-generation approach to immunology.
Generated from the website